Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

Clinical trial NCT06332131 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06332131
Sponsor: Abramson Cancer Center at Penn Medicine
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Coronary Microvascular Dysfunction Cardiotoxicity Breast Cancer Lung Cancer (NSCLC)

Start date: 2025-01-15
Primary completion: 2026-07-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.